This system showed that effective suppression of LPS-induced inflammation and TNF-α expression was achieved by the delivery of NPSC/siRNA in vivo, which provided a good method for increasing the efficacy of therapeutic siRNA in the treatment of autoimmune disorders such as RA [55]. Here, TNF is linked to rheumatoid arthritis.